Sandoz

📍 Basel, Switzerland👥 17,165 employees💰 Last funded Dec 2011
Pharmaceutical Manufacturing🌐 sandoz.com
Website LinkedIn
Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion. Read our community engagement guidelines: http://bit.ly/4ofoggc
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Brazil
1
Frequently asked questions
Who invested in Sandoz?
Sandoz has 1 investors on record on gritt.io.
When did Sandoz last raise funding?
The most recent investment in Sandoz recorded on gritt.io was in December 2011.
What industry is Sandoz in?
Sandoz operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Sandoz based?
Sandoz is headquartered in Basel, Switzerland.